Particle.news

Download on the App Store

Semaglutide Cuts Cocaine-Seeking in Rats, Fueling Calls for Human Trials

A peer-reviewed rat study reported reduced cocaine use metrics, with human efficacy still unproven.

Overview

  • Researchers at the University of Gothenburg and the University of Pennsylvania found semaglutide cut rat cocaine self-administration by 26%, reduced seeking after abstinence by 62%, and lowered motivation by 52%.
  • Male rats self-administered intravenous cocaine via a lever, then an experimental group received semaglutide before subsequent access in the paradigm.
  • Semaglutide suppressed cocaine-evoked dopamine in the nucleus accumbens, consistent with effects on reward-circuit activity.
  • The study was published in European Neuropsychopharmacology, and an independent expert said the carefully conducted work should prompt clinical trials for stimulant use disorder.
  • Semaglutide, sold as Ozempic and Wegovy, has shown signals for reducing alcohol use in controlled human trials, yet no medication is currently approved for cocaine dependence.